BETA
Home MEPs Dossiers Committees Subjects Blog About Dumps
download json


2015/0309(CNS) Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead LIBE BONI Michał (icon: PPE PPE) HEDH Anna (icon: S&D S&D), PAGAZAURTUNDÚA Maite (icon: ALDE ALDE), VALERO Bodil (icon: Verts/ALE Verts/ALE)
Committee Opinion ENVI
Lead committee dossier:

Events

2016/07/02
   Final act published in Official Journal
Details

PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2016/1070 on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

CONTENT: the Council adopted an implementing decision on subjecting the new psychoactive substance 1 -phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP ) to control measures across the Union.

α-PVP is a potent psychostimulant, structurally related to cathinone, pyrovalerone and methylendioxypyrovaleron (MDPV), which are controlled under the 1971 United Nations Convention on Psychotropic Substances.

The implementing Decision implements Decision 2005/387/JHA that confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union.

A risk assessment report on the new psychoactive substance α-PVP was drawn up in accordance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

There is no available information or any published study assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects to those observed in other stimulants.

Despite the limited scientific evidence available on α-PVP, the evidence and information on the health risks that the substance poses , as documented in its detection in fatalities and acute intoxications, provides sufficient grounds for subjecting α-PVP to control measures across the Union.

By 3 July 2017 , Member States shall take the necessary measures, in accordance with their national law, to subject the new psychoactive substance to control measures and criminal penalties, as provided for under their legislation, complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances.

The United Kingdom is not bound by Decision 2005/387/JHA and is therefore not taking part in the adoption of this Decision, which implements Decision 2005/387/JHA, and is not bound by it or subject to its application.

ENTRY INTO FORCE: 3.8.2016.

Documents
Decision 2016/1070
OJ L 178 02.07.2016, p. 0018
2016/06/27
   EP/CSL - Act adopted by Council after consultation of Parliament
2016/06/27
   EP - End of procedure in Parliament
2016/06/27
   CSL - Council Meeting
2016/06/08
   EP - Results of vote in Parliament
Documents
Results of vote in Parliament
2016/06/08
   EP - Decision by Parliament
Details

The European Parliament adopted by 646 votes to 7, with 21 abstentions, a legislative resolution on the draft Council decision on subjecting the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one ( α -pyrrolidinovalerophenone, α -PVP) to control measures.

In line with the recommendation made by the Committee on Civil Liberties, Justice and Home Affairs, Parliament approved the draft Council decision which aims to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.

Documents
T8-0258/2016
2016/05/10
   EP - Committee report tabled for plenary, 1st reading/single reading
Details

The Committee on Civil Liberties, Justice and Home Affairs adopted, in the framework of a special legislative procedure (Parliament’s consultation), the report by Michał BONI (EPP, PL) on the draft Council decision on subjecting the new psychoactive substance 1phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, αPVP) to control measures.

The committee approved the draft Council decision without amendments.

To recall, the proposed Decision seeks to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.

Documents
A8-0175/2016
2016/04/28
   EP - Vote in committee
2016/04/11
   EP - Committee referral announced in Parliament
2016/03/16
   EP - Committee draft report
Documents
PE578.806
2016/02/29
   EP - BONI Michał (PPE) appointed as rapporteur in LIBE
2015/12/21
   CSL - Legislative proposal
Details

PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

PROPOSED ACT: Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: a risk assessment report on the new psychoactive substance α-PVP was drawn up in compliance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015.

α-PVP is a potent psychostimulant , structurally related to cathinone, pyrovalerone and Methylendioxypyrovaleron (MDPV) which are controlled under the 1971 United Nations Convention on Psychotropic Substances.

There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

α-PVP has no established or acknowledged medical use (human or veterinary).

Despite the limited scientific evidence available on α -PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient ground for subjecting α -PVP to control measures across the Union.

CONTENT: the proposed Decision seeks to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one ( α -pyrrolidinovalerophenone, α -PVP) to control measures across the Union .

Since sixteen Member States control α -PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

For further details, please report to the summary of the Commission’s initial legislative proposal of 18.12.2015.

Documents
15386/2015
2015/12/20
   EC - Legislative proposal published
Details

PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

PROPOSED ACT: Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: a risk assessment report on the new psychoactive substance α-PVP was drawn up in compliance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015.

α-PVP is a potent psychostimulant , structurally related to cathinone, pyrovalerone and Methylendioxypyrovaleron (MDPV) which are controlled under the 1971 United Nations Convention on Psychotropic Substances.

There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

α-PVP has no established or acknowledged medical use (human or veterinary).

Despite the limited scientific evidence available on α -PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient ground for subjecting α -PVP to control measures across the Union.

CONTENT: the proposed Decision seeks to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one ( α -pyrrolidinovalerophenone, α -PVP) to control measures across the Union .

Since sixteen Member States control α -PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

For further details, please report to the summary of the Commission’s initial legislative proposal of 18.12.2015.

Documents
15386/2015
2015/12/18
   EC - Initial legislative proposal published
Details

PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

PROPOSED ACT: Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA . In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015.

α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe.

There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants.

According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union.

CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

Documents
COM(2015)0674
EUR-Lex

Documents

Activities

Votes

A8-0175/2016 - Michał Boni - Vote unique #

2016/06/08 Outcome: +: 646, 0: 21, -: 7
DE FR IT ES PL GB RO PT CZ HU SE EL BG NL BE AT DK SK FI HR LT IE SI LV LU MT EE CY
Total
92
69
64
49
48
47
27
21
21
19
18
18
17
25
19
17
12
12
11
11
10
10
8
7
6
6
5
5
icon: PPE PPE
199

Germany PPE

33

France PPE

17

Italy PPE

13

Spain PPE

13

Poland PPE

22

Romania PPE

10

Portugal PPE

7

Czechia PPE

7

Hungary PPE

11

Sweden PPE

4

Greece PPE

3

Bulgaria PPE

7

Netherlands PPE

5

Belgium PPE

4

Austria PPE

5

Denmark PPE

For (1)

Bendt BENDTSEN
1

Slovakia PPE

6

Finland PPE

3

Croatia PPE

5

Lithuania PPE

2

Ireland PPE

4

Slovenia PPE

5

Latvia PPE

4

Luxembourg PPE

3

Malta PPE

3

Estonia PPE

For (1)

Tunne KELAM
1

Cyprus PPE

1
icon: S&D S&D
175

Germany S&D

25

France S&D

13

Italy S&D

28

Spain S&D

13

Poland S&D

5

United Kingdom S&D

17

Romania S&D

14

Portugal S&D

8

Czechia S&D

4

Hungary S&D

4

Sweden S&D

4

Greece S&D

3

Bulgaria S&D

4

Netherlands S&D

3

Belgium S&D

4

Austria S&D

4

Denmark S&D

3

Slovakia S&D

4

Finland S&D

1

Croatia S&D

2

Lithuania S&D

2

Ireland S&D

For (1)

Nessa CHILDERS
1

Slovenia S&D

For (1)

Tanja FAJON
1

Latvia S&D

1

Luxembourg S&D

For (1)

Mady DELVAUX
1

Malta S&D

3

Estonia S&D

For (1)

Marju LAURISTIN
1

Cyprus S&D

2
icon: ALDE ALDE
64

Germany ALDE

4

France ALDE

7

Spain ALDE

8

United Kingdom ALDE

1

Romania ALDE

2

Portugal ALDE

2

Czechia ALDE

4

Sweden ALDE

3

Bulgaria ALDE

4

Netherlands ALDE

7

Belgium ALDE

4

Austria ALDE

For (1)

Angelika MLINAR
1

Denmark ALDE

3

Finland ALDE

3

Croatia ALDE

2

Lithuania ALDE

3

Ireland ALDE

For (1)

Marian HARKIN
1

Slovenia ALDE

For (1)

Ivo VAJGL
1

Luxembourg ALDE

For (1)

Charles GOERENS
1

Estonia ALDE

3
icon: ECR ECR
59

Germany ECR

6

Italy ECR

2

Poland ECR

17

United Kingdom ECR

13

Czechia ECR

2

Greece ECR

For (1)

Notis MARIAS
1

Bulgaria ECR

2

Netherlands ECR

2

Belgium ECR

4

Denmark ECR

3

Slovakia ECR

2

Finland ECR

2

Croatia ECR

For (1)

Ruža TOMAŠIĆ
1

Lithuania ECR

1

Latvia ECR

For (1)

Roberts ZĪLE
1
icon: GUE/NGL GUE/NGL
51

Germany GUE/NGL

8

France GUE/NGL

4

Italy GUE/NGL

3

Spain GUE/NGL

11

United Kingdom GUE/NGL

1

Portugal GUE/NGL

4

Czechia GUE/NGL

3

Sweden GUE/NGL

For (1)

Malin BJÖRK
1

Greece GUE/NGL

6

Netherlands GUE/NGL

2

Denmark GUE/NGL

For (1)

Rina Ronja KARI
1

Finland GUE/NGL

For (1)

Merja KYLLÖNEN
1

Ireland GUE/NGL

4

Cyprus GUE/NGL

2
icon: Verts/ALE Verts/ALE
46

Germany Verts/ALE

12

France Verts/ALE

5

Spain Verts/ALE

4

United Kingdom Verts/ALE

5

Hungary Verts/ALE

2

Sweden Verts/ALE

4

Netherlands Verts/ALE

2

Belgium Verts/ALE

2

Austria Verts/ALE

3

Denmark Verts/ALE

For (1)

Margrete AUKEN
1

Finland Verts/ALE

For (1)

Heidi HAUTALA
1

Croatia Verts/ALE

For (1)

Davor ŠKRLEC
1

Lithuania Verts/ALE

For (1)

Bronis ROPĖ
1

Slovenia Verts/ALE

For (1)

Igor ŠOLTES
1

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

Claude TURMES
1
icon: ENF ENF
38

Germany ENF

For (1)

Marcus PRETZELL
1

France ENF

20

Italy ENF

4

Poland ENF

For (1)

Michał MARUSIK

Abstain (1)

Stanisław ŻÓŁTEK
2

United Kingdom ENF

Abstain (1)

Janice ATKINSON
1

Romania ENF

1

Netherlands ENF

4

Belgium ENF

Against (1)

Gerolf ANNEMANS
1

Austria ENF

4
icon: EFDD EFDD
28

Germany EFDD

Abstain (1)

Beatrix von STORCH
1

Italy EFDD

14

Poland EFDD

1

United Kingdom EFDD

8

Czechia EFDD

Abstain (1)

Petr MACH
1

Sweden EFDD

2

Lithuania EFDD

For (1)

Rolandas PAKSAS
1
icon: NI NI
14

Germany NI

2

France NI

Against (1)

Jean-Marie LE PEN
3

Poland NI

Abstain (1)

Janusz KORWIN-MIKKE
1

United Kingdom NI

For (1)

Diane DODDS
1

Hungary NI

2

Greece NI

5

History

(these mark the time of scraping, not the official date of the change)

2023-08-03Show (2) Changes | Timetravel
docs/0
date
2015-12-21T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=15386%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 15386/2015
summary
type
Legislative proposal
body
CSL
events/1/date
Old
2015-12-21T00:00:00
New
2015-12-20T00:00:00
2021-12-18Show (8) Changes | Timetravel
docs/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE578.806
New
https://www.europarl.europa.eu/doceo/document/LIBE-PR-578806_EN.html
events/2/type
Old
Committee referral announced in Parliament, 1st reading/single reading
New
Committee referral announced in Parliament
events/3/type
Old
Vote in committee, 1st reading/single reading
New
Vote in committee
events/4/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/A-8-2016-0175_EN.html
New
https://www.europarl.europa.eu/doceo/document/A-8-2016-0175_EN.html
events/6
date
2016-06-08T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2016-0258_EN.html title: T8-0258/2016
summary
events/6
date
2016-06-08T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-8-2016-0258_EN.html title: T8-0258/2016
summary
procedure/Modified legal basis
Rules of Procedure EP 159
procedure/Other legal basis
Rules of Procedure EP 159
2020-01-19Show (4) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: BONI Michał date: 2016-02-29T00:00:00 group: European People's Party (Christian Democrats) abbr: PPE
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2016-02-29T00:00:00
rapporteur
name: BONI Michał group: European People's Party (Christian Democrats) abbr: PPE
shadows
events/4/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0175&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-8-2016-0175_EN.html
events/6/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0258
New
http://www.europarl.europa.eu/doceo/document/TA-8-2016-0258_EN.html
2019-07-12Show (2) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2016-02-29T00:00:00
rapporteur
name: BONI Michał group: European People's Party (Christian Democrats) abbr: PPE
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2016-02-29T00:00:00
rapporteur
name: BONI Michał group: Group of European People's Party abbr: EPP
shadows
2019-07-06Show (16) Changes | Timetravel
activities
  • date: 2015-12-18T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2015/0674/COM_COM(2015)0674_EN.pdf title: COM(2015)0674 type: Initial legislative proposal published celexid: CELEX:52015PC0674:EN body: EC commission: DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Initial legislative proposal published
  • date: 2015-12-21T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=15386%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 15386/2015 body: EC commission: DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Legislative proposal published
  • date: 2016-04-11T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał
  • date: 2016-04-28T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał
  • body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0175&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0175/2016 type: Committee report tabled for plenary, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP shadows: group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: Verts/ALE name: VALERO Bodil responsible: True committee: LIBE date: 2016-02-29T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał date: 2016-05-10T00:00:00
  • date: 2016-06-08T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0258 type: Decision by Parliament, 1st reading/single reading title: T8-0258/2016 body: EP type: Decision by Parliament, 1st reading/single reading
  • date: 2016-06-27T00:00:00 body: CSL type: Council Meeting council: Agriculture and Fisheries meeting_id: 3479
  • date: 2016-06-27T00:00:00 body: EP type: End of procedure in Parliament
  • date: 2016-06-27T00:00:00 body: EP/CSL type: Act adopted by Council after consultation of Parliament
  • date: 2016-07-02T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070 title: Decision 2016/1070 url: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2016:178:TOC title: OJ L 178 02.07.2016, p. 0018 type: Final act published in Official Journal
commission
  • body: EC dg: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2016-02-29T00:00:00
rapporteur
name: BONI Michał group: Group of European People's Party abbr: EPP
shadows
committees/0
body
EP
responsible
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
opinion
False
committees/1
body
EP
shadows
responsible
True
committee
LIBE
date
2016-02-29T00:00:00
committee_full
Civil Liberties, Justice and Home Affairs
rapporteur
group: EPP name: BONI Michał
council
  • body: CSL type: Council Meeting council: Agriculture and Fisheries meeting_id: 3479 url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3479*&MEET_DATE=27/06/2016 date: 2016-06-27T00:00:00
docs
  • date: 2016-03-16T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE578.806 title: PE578.806 type: Committee draft report body: EP
events
  • date: 2015-12-18T00:00:00 type: Initial legislative proposal published body: EC docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2015/0674/COM_COM(2015)0674_EN.pdf title: COM(2015)0674 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2015&nu_doc=0674 title: EUR-Lex summary: PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances. PROPOSED ACT: Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA . In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015. α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe. There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected. There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants. According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union. CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances. Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.
  • date: 2015-12-21T00:00:00 type: Legislative proposal published body: EC docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=15386%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 15386/2015 summary: PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures. PROPOSED ACT: Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: a risk assessment report on the new psychoactive substance α-PVP was drawn up in compliance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015. α-PVP is a potent psychostimulant , structurally related to cathinone, pyrovalerone and Methylendioxypyrovaleron (MDPV) which are controlled under the 1971 United Nations Convention on Psychotropic Substances. There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected. α-PVP has no established or acknowledged medical use (human or veterinary). Despite the limited scientific evidence available on α -PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient ground for subjecting α -PVP to control measures across the Union. CONTENT: the proposed Decision seeks to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one ( α -pyrrolidinovalerophenone, α -PVP) to control measures across the Union . Since sixteen Member States control α -PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose. For further details, please report to the summary of the Commission’s initial legislative proposal of 18.12.2015.
  • date: 2016-04-11T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2016-04-28T00:00:00 type: Vote in committee, 1st reading/single reading body: EP
  • date: 2016-05-10T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0175&language=EN title: A8-0175/2016 summary: The Committee on Civil Liberties, Justice and Home Affairs adopted, in the framework of a special legislative procedure (Parliament’s consultation), the report by Michał BONI (EPP, PL) on the draft Council decision on subjecting the new psychoactive substance 1phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, αPVP) to control measures. The committee approved the draft Council decision without amendments. To recall, the proposed Decision seeks to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.
  • date: 2016-06-08T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=27199&l=en title: Results of vote in Parliament
  • date: 2016-06-08T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0258 title: T8-0258/2016 summary: The European Parliament adopted by 646 votes to 7, with 21 abstentions, a legislative resolution on the draft Council decision on subjecting the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one ( α -pyrrolidinovalerophenone, α -PVP) to control measures. In line with the recommendation made by the Committee on Civil Liberties, Justice and Home Affairs, Parliament approved the draft Council decision which aims to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.
  • date: 2016-06-27T00:00:00 type: Act adopted by Council after consultation of Parliament body: EP/CSL
  • date: 2016-06-27T00:00:00 type: End of procedure in Parliament body: EP
  • date: 2016-07-02T00:00:00 type: Final act published in Official Journal summary: PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures. NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2016/1070 on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. CONTENT: the Council adopted an implementing decision on subjecting the new psychoactive substance 1 -phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP ) to control measures across the Union. α-PVP is a potent psychostimulant, structurally related to cathinone, pyrovalerone and methylendioxypyrovaleron (MDPV), which are controlled under the 1971 United Nations Convention on Psychotropic Substances. The implementing Decision implements Decision 2005/387/JHA that confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union. A risk assessment report on the new psychoactive substance α-PVP was drawn up in accordance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). There is no available information or any published study assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects to those observed in other stimulants. Despite the limited scientific evidence available on α-PVP, the evidence and information on the health risks that the substance poses , as documented in its detection in fatalities and acute intoxications, provides sufficient grounds for subjecting α-PVP to control measures across the Union. By 3 July 2017 , Member States shall take the necessary measures, in accordance with their national law, to subject the new psychoactive substance to control measures and criminal penalties, as provided for under their legislation, complying with their obligations under the 1971 United Nations Convention on Psychotropic Substances. The United Kingdom is not bound by Decision 2005/387/JHA and is therefore not taking part in the adoption of this Decision, which implements Decision 2005/387/JHA, and is not bound by it or subject to its application. ENTRY INTO FORCE: 3.8.2016. docs: title: Decision 2016/1070 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070 title: OJ L 178 02.07.2016, p. 0018 url: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2016:178:TOC
links
other
  • body: EC dg: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure/Modified legal basis
Old
Rules of Procedure of the European Parliament EP 150
New
Rules of Procedure EP 159
procedure/dossier_of_the_committee
Old
LIBE/8/05453
New
  • LIBE/8/05453
procedure/final/url
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070
New
https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070
procedure/subject
Old
  • 4.20.03 Drug addiction, alcoholism, smoking
  • 7.30.30.04 Action to combat drugs and drug-trafficking
New
4.20.03
Drug addiction, alcoholism, smoking
7.30.30.04
Action to combat drugs and drug-trafficking
procedure/title
Old
Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. Implementing Decision
New
Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures
2016-07-06Show (6) Changes | Timetravel
activities/6
date
2016-06-27T00:00:00
body
CSL
type
Council Meeting
council
Agriculture and Fisheries
meeting_id
3479
activities/7
date
2016-06-27T00:00:00
body
EP
type
End of procedure in Parliament
activities/8
date
2016-06-27T00:00:00
body
EP/CSL
type
Act adopted by Council after consultation of Parliament
activities/9
date
2016-07-02T00:00:00
docs
type
Final act published in Official Journal
procedure/final
url
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32016D1070
title
Decision 2016/1070
procedure/stage_reached
Old
Awaiting final decision
New
Procedure completed
2016-07-05Show (1) Changes | Timetravel
procedure/title
Old
New psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, α-PVP): control measures
New
Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures. Implementing Decision
2016-06-17Show (1) Changes | Timetravel
activities/5/docs/0/text

  • The European Parliament adopted by 646 votes to 7, with 21 abstentions, a legislative resolution on the draft Council decision on subjecting the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

    In line with the recommendation made by the Committee on Civil Liberties, Justice and Home Affairs, Parliament approved the draft Council decision which aims to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.
2016-06-10Show (3) Changes | Timetravel
activities/5/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0258 type: Decision by Parliament, 1st reading/single reading title: T8-0258/2016
activities/5/type
Old
Vote in plenary scheduled
New
Decision by Parliament, 1st reading/single reading
procedure/stage_reached
Old
Awaiting Parliament 1st reading / single reading / budget 1st stage
New
Awaiting final decision
2016-06-05Show (1) Changes | Timetravel
activities/4/docs/0/text

  • The Committee on Civil Liberties, Justice and Home Affairs adopted, in the framework of a special legislative procedure (Parliament’s consultation), the report by Michał BONI (EPP, PL) on the draft Council decision on subjecting the new psychoactive substance 1phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, αPVP) to control measures.

    The committee approved the draft Council decision without amendments.

    To recall, the proposed Decision seeks to subject the new psychoactive substance, α-PVP, a potent psychostimulant, to control measures across the Union.
2016-05-28Show (2) Changes | Timetravel
activities/5/date
Old
2016-06-07T00:00:00
New
2016-06-08T00:00:00
activities/5/type
Old
Indicative plenary sitting date, 1st reading/single reading
New
Vote in plenary scheduled
2016-05-26Show (1) Changes | Timetravel
activities/4/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0175&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0175/2016
2016-05-12Show (2) Changes | Timetravel
activities/4
date
2016-05-10T00:00:00
body
EP
type
Committee report tabled for plenary, 1st reading/single reading
committees
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
2016-05-05Show (2) Changes | Timetravel
activities/3
date
2016-04-28T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
procedure/Modified legal basis
Rules of Procedure of the European Parliament EP 150
2016-04-23Show (2) Changes | Timetravel
activities/2/committees/1/shadows
  • group: S&D name: HEDH Anna
  • group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite
  • group: Verts/ALE name: VALERO Bodil
committees/1/shadows
  • group: S&D name: HEDH Anna
  • group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite
  • group: Verts/ALE name: VALERO Bodil
2016-04-13Show (3) Changes | Timetravel
activities/2
date
2016-04-11T00:00:00
body
EP
type
Committee referral announced in Parliament, 1st reading/single reading
committees
procedure/dossier_of_the_committee
LIBE/8/05453
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision
2016-04-06Show (1) Changes | Timetravel
activities/2
date
2016-06-07T00:00:00
body
EP
type
Indicative plenary sitting date, 1st reading/single reading
2016-03-30Show (1) Changes | Timetravel
activities/1/docs/0/text

  • PURPOSE: to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures.

    PROPOSED ACT: Council Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND: a risk assessment report on the new psychoactive substance α-PVP was drawn up in compliance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction, and was subsequently submitted to the Commission and to the Council on 27 November 2015.

    α-PVP is a potent psychostimulant, structurally related to cathinone, pyrovalerone and Methylendioxypyrovaleron (MDPV) which are controlled under the 1971 United Nations Convention on Psychotropic Substances.

    There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

    α-PVP has no established or acknowledged medical use (human or veterinary).

    Despite the limited scientific evidence available on α-PVP, the evidence and information on the health risks that the substance poses, as documented in its detection in fatalities and acute intoxications, provides sufficient ground for subjecting α-PVP to control measures across the Union.

    CONTENT: the proposed Decision seeks to subject the new psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1one (α-pyrrolidinovalerophenone, α-PVP) to control measures across the Union.

    Since sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it, subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

    For further details, please report to the summary of the Commission’s initial legislative proposal of 18.12.2015.
2016-03-17Show (1) Changes | Timetravel
activities/0/docs/0/text

  • PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

    PROPOSED ACT: Council Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND:  the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA. In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015.

    α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe.

    There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

    There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants.

    According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union.

    CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

    Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.

2016-03-11Show (4) Changes | Timetravel
activities/0/docs/0/text

  • PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

    PROPOSED ACT: Council Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND:  the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA. In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015.

    α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe.

    There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

    There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants.

    According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union.

    CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

    Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.
activities/0/docs/0/type
Old
Legislative proposal published
New
Initial legislative proposal published
activities/0/type
Old
Legislative proposal published
New
Initial legislative proposal published
activities/1
date
2015-12-21T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=15386%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 15386/2015
body
EC
commission
DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
type
Legislative proposal published
2016-02-27Show (2) Changes | Timetravel
committees/1/date
2016-02-29T00:00:00
committees/1/rapporteur
  • group: EPP name: BONI Michał
2016-01-21Show (1) Changes | Timetravel
activities/0/docs/0/text

  • PURPOSE: to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

    PROPOSED ACT: Council Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND:  the risks of α-PVP were assessed by the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addition (EMCDDA), acting in compliance with the provisions of Council Decision 2005/387/JHA. In particular, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substance α-PVP. The Chair of the Scientific Committee submitted the risk assessment report to the Commission and to the Council on 27 November 2015.

    α-PVP is a potent psychostimulant. The substance detected in all 28 Member States as well as in Turkey and Norway, is mainly imported into the EU drug market from China and then distributed across Europe.

    There have been a total of 115 deaths and 191 acute intoxications registered in eight Member States reported where α-PVP was detected.

    There is no available information or published studies assessing in a comprehensive way the health risks associated with α-PVP, namely chronic and acute toxicity, but observations in animals suggest similar effects with those observed with other stimulants.

    According to the risk assessment report, the acute toxicity of α-PVP is such that it can cause severe harms to the health of individuals. Therefore, the Commission considered that there are grounds for subjecting this substance to control measures across the Union.

    CONTENT: the objective of this proposal for a Council Decision is to call upon the Member States to subject α-PVP to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances.

    Currently, sixteen Member States control α-PVP under national legislation complying with the obligations of the 1971 United Nations Convention on Psychotropic Substances and five Member States use other legislative measures to control it. Subjecting this substance to control measures across the Union would help avoid the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protect from the risks that its availability and use can pose.
2016-01-14Show (5) Changes
activities
  • date: 2015-12-18T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2015/0674/COM_COM(2015)0674_EN.pdf celexid: CELEX:52015PC0674:EN type: Legislative proposal published title: COM(2015)0674 body: EC type: Legislative proposal published commission: DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
committees
  • body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI
  • body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
links
other
  • body: EC dg: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure
reference
2015/0309(CNS)
instrument
Decision
title
New psychoactive substance 1-phenyl-2-(1-pyrrolidin-1-yl) pentan-1-one (α-pyrrolidinovalerophenone, α-PVP): control measures
stage_reached
Preparatory phase in Parliament
subtype
Legislation
type
CNS - Consultation procedure
subject
@parltrack
@parltrack@eupolicy.social
[javascript protected email address]
code AGPLv3.0+
data ODBLv1.0
site content CC-By-Sa-3.0

ParlTrack - 2011-2024

© European Union, 2011 – Source: European Parliament
Hosted by AS250.net Foundation